Loading..
  • SV
  • ENG

Enzymatica logoEnzymatica logo

Loading..
  • SV
  • ENG
  • About us
    About us
    • Our Company
      Barrier technology
      Vision
      Business concept
    • Goals
      Growth strategy
      Distributor network
    • Organization
      Board of Directors
      Management
      History
    • Sustainability
      Code of conduct
      Career
  • Research & Development
    Research & Development
    • Introduction
    • Product development
    • ColdZyme studies
    • Scientific advisors
  • Products
    Products
    • ColdZyme® against common cold
  • Corporate Governance
    Corporate Governance
    • Corporate governance structure
      Corporate governance reports
      General Meeting
      General Meetings
    • Nomination Committee
      Board of Directors
      Chairman of the Board
      Board meetings
      Committees
    • Management
      Remuneration guidelines
      Auditor
    • Internal control
      Articles of Association
  • Investors
    Investors
    • Enzymatica on First North
      Certified Adviser
      Investment case
      Risks
    • The share
      Share capital
      Dividend
      Ownership structure
      Analyses
    • Financial reports
      Prospectus / Issues
      Press releases
      Presentations
    • Financial calendar
      Subscribe
      IR contact
  • Media
    Media
    • Press releases
      Image bank
    • Other news
      Enzymatica in the media
    • Subscribe
    • Media contact
  • Contacts
    Contacts
    • Offices
    • Investors
    • Media
    • About us
      • Our Company
      • Barrier technology
      • Vision
      • Business concept
      • Goals
      • Growth strategy
      • Distributor network
      • Organization
        • Board of Directors
        • Management
      • History
      • Sustainability
      • Code of conduct
      • Career
    • Research & Development
      • Introduction
      • Product development
      • ColdZyme studies
      • Scientific advisors
    • Products
      • ColdZyme® against common cold
    • Corporate Governance
      • Corporate governance structure
      • Corporate governance reports
      • General Meeting
        • General Meetings
      • Nomination Committee
      • Board of Directors
        • Chairman of the Board
        • Board meetings
        • Committees
      • Management
      • Remuneration guidelines
      • Auditor
      • Internal control
      • Articles of Association
    • Investors
      • Enzymatica on First North
        • Certified Adviser
      • Investment case
      • Risks
      • The share
        • Share capital
        • Dividend
        • Ownership structure
        • Analyses
      • Financial reports
      • Prospectus / Issues
      • Press releases
      • Presentations
      • Financial calendar
      • Subscribe
      • IR contact
    • Media
      • Press releases
      • Image bank
      • Other news
      • Enzymatica in the media
      • Subscribe
      • Media contact
    • Contacts
      • Office
      • Investors
      • Media

    Corporate governace report 2018

    April 1, 2019

    Documents

    • Enzymatica Governance Report 2018
      English 1 April, 2019
    • Corporate Governance
      • Corporate governance structure
      • Corporate governance reports
      • General Meeting
        • General Meetings
      • Nomination Committee
      • Board of Directors
        • Chairman of the Board
        • Board meetings
        • Committees
      • Management
      • Remuneration guidelines
      • Auditor
      • Internal control
      • Articles of Association
    • Privacy Policy

    Ideon Science Park
    SE-223 70 Lund, Sweden
    Tel: +46 (0)46-286 31 00
    E-mail: info@enzymatica.se

    Enzymatica cares about your privacy and processes your personal data in accordance with the EU’s General Data Protection Regulation. For more information about how we handle your personal information, and what rights you have, please refer to our personal data processing document here.

    OK